Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

Mon, 16th Oct 2023 07:44

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

More than one million people have fled their homes in Gaza in scenes of chaos and despair as Israel bombarded the Hamas-ruled Gaza Strip and continued amassing troops Monday in preparation for a full-blown ground invasion.

US President Joe Biden said in an interview with the CBS news programme 60 Minutes that while invading and "taking out the extremists" was needed, any move to occupy the territory would be a "big mistake". The US and Israel are discussing a Biden visit in the coming week.

Hamas backer Iran and Lebanon's Hezbollah, which is also supported by Tehran, have warned that an invasion would be met with a response. "No one can guarantee the control of the situation and the non-expansion of the conflicts" if Israel sends its soldiers into Gaza, said Iran's Foreign Minister Hossein Amir-Abdollahian.

The Israeli army said Monday it was evacuating residents living along its northern frontier with Lebanon amid rising tensions.

In early UK company news, Hipgnosis Songs Fund said it was withdrawing its proposed dividend, as it expects lower retroactive royalty payments. Electrolyser company ITM said it was beginning to bid on projects in the US market.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 27.7 points, 0.4%, at 7,627.3

----------

Hang Seng: down 1.1% at 17,611.34

Nikkei 225: closed down 2.0% at 31,659.03

S&P/ASX 200: closed down 0.4% at 7,026.50

----------

DJIA: closed up 39.15 points, or 0.1%, at 33,670.29

S&P 500: closed down 21.83 points, or 0.5%, at 4,327.78

Nasdaq Composite: closed down 166.99 points, or 1.2%, at 13,407.23

----------

EUR: up at USD1.0531 (USD1.0498)

GBP: up at USD1.2169 (USD1.2135)

USD: down at JPY149.48 (JPY149.66)

Gold: down at USD1,915.00 per ounce (USD1,922.99)

Oil (Brent): up at USD90.77 a barrel (USD89.59)

(changes since previous London equities close)

----------

ECONOMICS

----------

Monday's key economic events still to come:

EU Eurogroup meeting of eurozone finance ministers

1100 CEST EU foreign trade

1100 IST Ireland goods exports and imports

----------

UK house price growth was muted this month by October's usually loftier standards, numbers from Rightmove showed, though the property portal noted some calm is returning to the mortgage market. According to Rightmove, UK house prices rose 0.5% on-month in October, quickening slightly from September's 0.4% rise. However, this month's rise is markedly cooler than the 1.4% "historic norm" house price expansion usually delivered in October.

----------

A top German politician has indicated that the EU might be open to looking again at post-Brexit trading relations with the UK, telling politicians to "call us". German Finance Minister Christian Lindner told BBC News that the UK has a "standing invitation" on any future talks on reducing trade barriers or "obstacles in daily business life". "If you want to intensify your trade relationship with the EU – call us!" He told the broadcaster: "In the daily life of German corporates, there are new obstacles since Brexit… I don't think (the) UK is benefiting from Brexit. "We really appreciate the UK and its values, its people… and I would really, really appreciate it if we can intensify (the trading relationship) again," he said.

----------

BROKER RATING CHANGES

----------

Barclays cuts Ocado to 'underweight' (equal weight) - price target 430 (680) pence

----------

Jefferies raises Pennon Group to 'buy' (underperform) - price target 850 (700) pence

----------

Jefferies raises United Utilities to 'buy' (hold) - price target 1,200 (960) pence

----------

COMPANIES - FTSE 100

----------

GSK said it has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use regarding Jemperli in combination with carboplatin-paclitaxel for adults patients with certain endometrial cancer. Jemperli, or dostarlimab, is a monoclonal antibody, while carboplatin-paclitaxel is chemotherapy. The positive opinion is one of the final steps before the European Commission decides on whether to grant the treatment marketing authorisation, GSK noted.

----------

COMPANIES - FTSE 250

----------

Betting and gaming firm 888 confirmed Per Widerstrom has taken up his role as chief executive officer, as planned. Jonathan Mendelsohn has returned to his position as non-executive chair, having acted in an executive capacity since January 30. Widerstrom was most recently CEO of Fortuna Entertainment Group, a betting and gaming firm in central and eastern Europe.

----------

Hipgnosis Songs Fund said it has decided to withdraw its proposed interim dividend of 1.13 pence announced in late September. This is because the firm now expects to receive "significantly lower retroactive payments" in relation to the US Copyright Royalty Board's decision in relation to royalties payable to songwriters for the period covering 2018-2022. Hipgnosis's board intends to reduce its CRB III retroactive accrual to USD9.9 million from USD21.7 million at the end of March. The dividend withdrawal is to ensure compliance with a covenant within its revolving credit facility. "In addition, the company is in discussion with the agent and the lenders to avoid any potential impacts of the unwinding of the CRB III accrual on future fixed charge cover ratio covenant compliance," the fund added. "Subject to satisfactory conclusion to discussions with lenders, the board expects to declare and pay future dividends as targeted."

----------

OTHER COMPANIES

----------

ITM Power said it is commencing bidding into projects in the US market. The maker of electrolysers to produce green hydrogen said it will pursue an "accelerated, asset-light entry" into the US market, which is "widely recognised" as having the potential to become one of the largest markets for electrolysers. "The region's green hydrogen journey has just started, which provides ITM with a tremendous opportunity to become a leading electrolyser provider as the market develops over the coming years," said CEO Dennis Schulz.

----------

On The Beach said bookings for holidays in October and November are up 26% compared with a year ago. Some 58% of UK adults are considering or definitely going on holiday in that period, a survey commissioned by the travel retailer suggested. Zoe Harris, chief customer officer at On The Beach, said: "We all know that this summer has been a complete washout and according to our booking data it looks as though holidaymakers are searching for the last bit of sun."

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.